華爾街頂級分析師對這些頂尖公司改變了他們的展望。有關所有分析師評級變動的完整視圖，包括上調和下調，請查看我們的 分析師評級頁面。
<ul>
<li>Baird 將 CrowdStrike Holdings Inc. (NASDAQ: CRWD) 的目標價從 $460 上調至 $490，同時維持中性評級。CrowdStrike Holdings 的股票週一收於 $782.17。查看其他分析師對該股票的看法。</li>
<li>HC Wainwright &amp; Co. 將 Fulcrum Therapeutics Inc. (NASDAQ: FULC) 的目標價從 $25 下調至 $3，並將該股票評級從買入下調至中性。Fulcrum Therapeutics 的股票週一收於 $6.42。查看其他分析師對該股票的看法。</li>
<li>高盛將 HP Inc. (NYSE: HPQ) 的目標價從 $16 上調至 $19，同時維持賣出評級。HP 的股票週一收於 $29.34。查看其他分析師對該股票的看法。</li>
<li>HC Wainwright &amp; Co. 將 Praxis Precision Medicines Inc. (NASDAQ: PRAX) 的目標價從 $1,250 下調至 $1,200，並維持買入評級。Praxis Precision Medicines 的股票週一收於 $335.16。查看其他分析師對該股票的看法。</li>
<li>Ascendiant Capital 將 Genasys Inc. (NASDAQ: GNSS) 的目標價從 $5.50 上調至 $6，並維持買入評級。Genasys 的股票週一收於 $2.11。查看其他分析師對該股票的看法。</li>
<li>高盛將 Intuit Inc. (NASDAQ: INTU) 的目標價從 $519 下調至 $276，並將該股票評級從中性下調至賣出。Intuit 的股票週一收於 $353.76。查看其他分析師對該股票的看法。</li>
<li>Evercore ISI Group 將 Guardant Health Inc. (NASDAQ: GH) 的目標價從 $95 上調至 $160，並將該股票評級從持平上調至跑贏大盤。Guardant Health 的股票週一收於 $129.14。查看其他分析師對該股票的看法。</li>
<li>Needham 將 Credo Technology Group Holding Ltd. (NASDAQ: CRDO) 的目標價從 $220 上調至 $275，同時維持買入評級。Credo Technology Group Holding 的股票週一收於 $226.10。查看其他分析師對該股票的看法。</li>
<li>BTIG 將 Praxis Precision Medicines Inc. (NASDAQ: PRAX) 的目標價從 $843 下調至 $810，並維持買入評級。Praxis Precision Medicines 的股票週一收於 $335.16。查看其他分析師對該股票的看法。</li>
<li>BofA Securities 將 Nu Holdings Ltd. (NYSE: NU) 的目標價從 $16 下調至 $10，並將該股票評級從中性下調至表現不佳。Nu Holdings 的股票週一收於 $12.99。查看其他分析師對該股票的看法。</li>
</ul>

財捷

CRDO

惠普

PRAX

FULC

CRWD

華爾街分析師更新了幾隻股票的評級和目標價。Baird 將 CrowdStrike 的目標價上調至 490 美元；高盛將惠普的目標價上調至 19 美元，但將 Intuit 的目標價下調至 276 美元並給予降級。HC Wainwright 將 Fulcrum Therapeutics 的評級下調至中性，目標價為 3 美元。Evercore ISI 將 Guardant Health 的評級上調至跑贏大盤，目標價提高至 160 美元。Needham 將 Credo Technology 的目標價提高至 275 美元。BTIG 略微下調了 Praxis Precision Medicines 的目標價，而美銀則將 NU Holdings 的評級下調至跑輸大盤，目標價為 10 美元

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
<div class="lb-trans">華爾街頂級分析師對這些頂尖公司改變了他們的展望。有關所有分析師評級變動的完整視圖，包括上調和下調，請查看我們的 分析師評級頁面。
</div><ul>
<li>Baird raised the price target for CrowdStrike Holdings Inc. (NASDAQ: CRWD) from $460 to $490 while maintaining a Neutral rating. CrowdStrike Holdings shares closed at $782.17 on Monday. See how other analysts view this stock.</li>
<li>HC Wainwright &amp; Co. lowered the price target for Fulcrum Therapeutics Inc. (NASDAQ: FULC) from $25 to $3 and downgraded the stock from Buy to Neutral. Fulcrum Therapeutics shares closed at $6.42 on Monday. See how other analysts view this stock.</li>
<li>Goldman Sachs raised the price target for HP Inc. (NYSE: HPQ) from $16 to $19 while maintaining a Sell rating. HP shares closed at $29.34 on Monday. See how other analysts view this stock.</li>
<li>HC Wainwright &amp; Co. cut the price target for Praxis Precision Medicines Inc. (NASDAQ: PRAX) from $1,250 to $1,200 and maintained a Buy rating. Praxis Precision Medicines shares closed at $335.16 on Monday. See how other analysts view this stock.</li>
<li>Ascendiant Capital raised its price target for Genasys Inc. (NASDAQ: GNSS) from $5.50 to $6 and maintained a Buy rating. Genasys shares closed at $2.11 on Monday. See how other analysts view this stock.</li>
<li>Goldman Sachs lowered the price target for Intuit Inc. (NASDAQ: INTU) from $519 to $276 and downgraded the stock from Neutral to Sell. Intuit shares closed at $353.76 on Monday. See how other analysts view this stock.</li>
<li>Evercore ISI Group raised the price target for Guardant Health Inc. (NASDAQ: GH) from $95 to $160 and upgraded the stock from In-Line to Outperform. Guardant Health shares closed at $129.14 on Monday. See how other analysts view this stock.</li>
<li>Needham increased the price target for Credo Technology Group Holding Ltd. (NASDAQ: CRDO) from $220 to $275 while maintaining a Buy rating. Credo Technology Group Holding shares closed at $226.10 on Monday. See how other analysts view this stock.</li>
<li>BTIG lowered its price target for Praxis Precision Medicines Inc. (NASDAQ: PRAX) from $843 to $810 and maintained a Buy rating. Praxis Precision Medicines shares closed at $335.16 on Monday. See how other analysts view this stock.</li>
<li>BofA Securities cut the price target for Nu Holdings Ltd. (NYSE: NU) from $16 to $10 and downgraded the stock from Neutral to Underperform. Nu Holdings shares closed at $12.99 on Monday. See how other analysts view this stock.</li>
</ul>
<div class="lb-trans"><ul>
<li>Baird 將 CrowdStrike Holdings Inc. (NASDAQ: CRWD) 的目標價從 $460 上調至 $490，同時維持中性評級。CrowdStrike Holdings 的股票週一收於 $782.17。查看其他分析師對該股票的看法。</li>
<li>HC Wainwright &amp; Co. 將 Fulcrum Therapeutics Inc. (NASDAQ: FULC) 的目標價從 $25 下調至 $3，並將該股票評級從買入下調至中性。Fulcrum Therapeutics 的股票週一收於 $6.42。查看其他分析師對該股票的看法。</li>
<li>高盛將 HP Inc. (NYSE: HPQ) 的目標價從 $16 上調至 $19，同時維持賣出評級。HP 的股票週一收於 $29.34。查看其他分析師對該股票的看法。</li>
<li>HC Wainwright &amp; Co. 將 Praxis Precision Medicines Inc. (NASDAQ: PRAX) 的目標價從 $1,250 下調至 $1,200，並維持買入評級。Praxis Precision Medicines 的股票週一收於 $335.16。查看其他分析師對該股票的看法。</li>
<li>Ascendiant Capital 將 Genasys Inc. (NASDAQ: GNSS) 的目標價從 $5.50 上調至 $6，並維持買入評級。Genasys 的股票週一收於 $2.11。查看其他分析師對該股票的看法。</li>
<li>高盛將 Intuit Inc. (NASDAQ: INTU) 的目標價從 $519 下調至 $276，並將該股票評級從中性下調至賣出。Intuit 的股票週一收於 $353.76。查看其他分析師對該股票的看法。</li>
<li>Evercore ISI Group 將 Guardant Health Inc. (NASDAQ: GH) 的目標價從 $95 上調至 $160，並將該股票評級從持平上調至跑贏大盤。Guardant Health 的股票週一收於 $129.14。查看其他分析師對該股票的看法。</li>
<li>Needham 將 Credo Technology Group Holding Ltd. (NASDAQ: CRDO) 的目標價從 $220 上調至 $275，同時維持買入評級。Credo Technology Group Holding 的股票週一收於 $226.10。查看其他分析師對該股票的看法。</li>
<li>BTIG 將 Praxis Precision Medicines Inc. (NASDAQ: PRAX) 的目標價從 $843 下調至 $810，並維持買入評級。Praxis Precision Medicines 的股票週一收於 $335.16。查看其他分析師對該股票的看法。</li>
<li>BofA Securities 將 Nu Holdings Ltd. (NYSE: NU) 的目標價從 $16 下調至 $10，並將該股票評級從中性下調至表現不佳。Nu Holdings 的股票週一收於 $12.99。查看其他分析師對該股票的看法。</li>
</ul>
</div>

CrowdStrike 將上漲 7%？以下是週二的十大分析師預測